Neuroinflammatory changes, characterized by reactive astrocytes and activated microglia, are considered to be a secondary process following Aβ and tau accumulation and contribute greatly to neurodegeneration throughout the course of AD (Ingelsson et al., 2004). The gene discussed is MAPT; the disease is Alzheimer disease.